阳普医疗
(300030)
| 流通市值：19.11亿 | | | 总市值：21.70亿 |
| 流通股本：2.72亿 | | | 总股本：3.09亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 363,452,008.57 | 215,097,732 | 95,314,773.95 | 486,260,010.42 |
| 营业总成本 | 313,761,492.11 | 182,785,118.63 | 79,504,810.86 | 452,644,635.72 |
| 其他经营收益 | | | | |
| 营业利润 | 27,303,596.64 | 37,215,993.25 | 26,819,603.42 | 20,852,468.93 |
| 利润总额 | 27,584,356.39 | 37,472,816.77 | 26,819,317.73 | 22,717,559.24 |
| 净利润 | 19,884,915.26 | 31,320,389.47 | 21,966,657.97 | 15,214,212.98 |
| 每股收益 | | | | |
| 其他综合收益 | 85,232.14 | 76,090.43 | 32,802.24 | -990,517.45 |
| 综合收益总额 | 19,970,147.4 | 31,396,479.9 | 21,999,460.21 | 14,223,695.53 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 346,415,454.26 | 406,290,792.8 | 430,165,051.04 | 423,343,116.21 |
| 非流动资产: | | | | |
| 非流动资产合计 | 582,940,769.67 | 588,254,402.88 | 592,939,111.87 | 603,578,620.44 |
| 资产总计 | 929,356,223.93 | 994,545,195.68 | 1,023,104,162.91 | 1,026,921,736.65 |
| 流动负债: | | | | |
| 流动负债合计 | 216,813,054.8 | 268,608,831.79 | 295,564,848.01 | 317,872,845.65 |
| 非流动负债: | | | | |
| 非流动负债合计 | 44,117,142.01 | 46,084,004.27 | 50,442,764.22 | 53,951,800.53 |
| 负债合计 | 260,930,196.81 | 314,692,836.06 | 346,007,612.23 | 371,824,646.18 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 639,287,687.3 | 651,226,352.93 | 642,047,770.4 | 620,335,333.87 |
| 股东权益合计 | 668,426,027.12 | 679,852,359.62 | 677,096,550.68 | 655,097,090.47 |
| 负债和股东权益合计 | 929,356,223.93 | 994,545,195.68 | 1,023,104,162.91 | 1,026,921,736.65 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 418,663,467.45 | 275,771,949.73 | 135,377,412.25 | 585,506,044.48 |
| 经营活动现金流出小计 | 344,974,598.11 | 219,013,292.11 | 106,705,100.39 | 475,610,301.01 |
| 经营活动产生的现金流量净额 | 73,688,869.34 | 56,758,657.62 | 28,672,311.86 | 109,895,743.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 207,145,153.85 | 149,947,963.5 | 55,603,697.29 | 301,452,402.08 |
| 投资活动现金流出小计 | 238,803,448.03 | 174,775,157.99 | 98,401,226.94 | 296,474,354.1 |
| 投资活动产生的现金流量净额 | -31,658,294.18 | -24,827,194.49 | -42,797,529.65 | 4,978,047.98 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 36,592,998.53 | 26,592,998.53 | 25,859,675 | 231,400,000 |
| 筹资活动现金流出小计 | 138,342,996.53 | 88,308,900.74 | 46,568,102.51 | 434,720,186.92 |
| 筹资活动产生的现金流量净额 | -101,749,998 | -61,715,902.21 | -20,708,427.51 | -203,320,186.92 |
| 汇率变动对现金及现金等价物的影响 | -1,015,335.59 | -715,189.47 | -374,189.77 | 317,527.15 |
| 现金及现金等价物净增加额 | -60,734,758.43 | -30,499,628.55 | -35,207,835.07 | -88,128,868.32 |
| 期末现金及现金等价物余额 | 98,467,454.25 | 128,702,584.13 | 123,994,377.61 | 159,202,212.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -30,499,628.55 | - | -88,128,868.32 |